R

Redpin Therapeutics

2 employees

Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2017

Funding rounds raised

Total raised

$16M

from 1 investors over 1 rounds

R

Redpin Therapeutics raised $16M on March 25, 2020

Investors: Takeda UK Limited

FAQ